BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 22266696)

  • 1. Beyond effect size: consideration of the minimum effect size of interest in anesthesia trials.
    Gibbs NM; Weightman WM
    Anesth Analg; 2012 Feb; 114(2):471-5. PubMed ID: 22266696
    [No Abstract]   [Full Text] [Related]  

  • 2. The clinician as investigator: participating in clinical trials in the practice setting: Appendix 2: statistical concepts in study design and analysis.
    Lader EW; Cannon CP; Ohman EM; Newby LK; Sulmasy DP; Barst RJ; Fair JM; Flather M; Freedman JE; Frye RL; Hand MM; Jesse RL; Van de Werf F; Costa F;
    Circulation; 2004 Jun; 109(21):e305-7. PubMed ID: 15173053
    [No Abstract]   [Full Text] [Related]  

  • 3. Unbelievable Folly of Clinical Trials in Heart Failure: The Inconvenient Truth About How Investigators and Guidelines Weigh Evidence.
    Packer M
    Circ Heart Fail; 2016 Apr; 9(4):e002837. PubMed ID: 27009552
    [No Abstract]   [Full Text] [Related]  

  • 4. A mixture gatekeeping procedure based on the Hommel test for clinical trial applications.
    Brechenmacher T; Xu J; Dmitrienko A; Tamhane AC
    J Biopharm Stat; 2011 Jul; 21(4):748-67. PubMed ID: 21516567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adaptive methods: telling "the rest of the story".
    Emerson SS; Fleming TR
    J Biopharm Stat; 2010 Nov; 20(6):1150-65. PubMed ID: 21058111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Documentation of endpoint prevention with combination therapy in hypertension is urgently needed.
    Kjeldsen SE; Oparil S; Hedner T; Narkiewicz K
    Blood Press; 2007; 16(1):4-5. PubMed ID: 17453745
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical intervention trials: planning, performance and interpretation].
    Elmfeldt D
    Cardiologia; 1984; 29(1-2):43-51. PubMed ID: 6543494
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative prophylactic and therapeutic effects of intravenous labetalol 0.4 mg/kg and nicardipine 20 μg/kg on hypertensive responses to endotracheal intubation in patients undergoing elective surgeries with general anesthesia: a prospective, randomized, double-blind study.
    Ryu JH; Apfel CC; Whelan R; Jeon YT; Hwang JW; Do SH; Ro YJ; Kim CS
    Clin Ther; 2012 Mar; 34(3):593-604. PubMed ID: 22364823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Power and sample size.
    Case LD; Ambrosius WT
    Methods Mol Biol; 2007; 404():377-408. PubMed ID: 18450060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statistical considerations on design and analysis of bridging and multiregional clinical trials.
    Tsong Y
    J Biopharm Stat; 2012 Sep; 22(5):1078-80. PubMed ID: 22946952
    [No Abstract]   [Full Text] [Related]  

  • 11. A new partition testing strategy for multiple endpoints.
    Wang B; Cui X
    Stat Med; 2012 Sep; 31(20):2151-68. PubMed ID: 22532094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On sample size determination in multi-armed confirmatory adaptive designs.
    Wassmer G
    J Biopharm Stat; 2011 Jul; 21(4):802-17. PubMed ID: 21516570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-of-1 trials in oncology.
    Collette L; Tombal B
    Lancet Oncol; 2015 Aug; 16(8):885-6. PubMed ID: 26248830
    [No Abstract]   [Full Text] [Related]  

  • 14. [Does urapidil attenuate the hypertensive response to tracheal intubation at the time of general anesthesia?].
    Quéré JF; Ozier Y; Bringier J; Morot B; Bernard D; Pigot B; Conseiller C
    Cah Anesthesiol; 1990 Nov; 38(5):343-4. PubMed ID: 2285871
    [No Abstract]   [Full Text] [Related]  

  • 15. Qualitative consistency of treatment effects in multiregional clinical trials.
    Tanaka Y; Li G; Wang Y; Chen J
    J Biopharm Stat; 2012 Sep; 22(5):988-1000. PubMed ID: 22946945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Arterial hypertension: an update].
    Verdecchia P; Angeli F; Mazzotta G; Gentile G; Reboldi G
    G Ital Cardiol (Rome); 2010 May; 11(5 Suppl 3):74S-77S. PubMed ID: 20879486
    [No Abstract]   [Full Text] [Related]  

  • 17. Note on special technical issue on adaptive designs for clinical trials.
    Liu Q; Chang M
    J Biopharm Stat; 2012; 22(4):615-6. PubMed ID: 22651104
    [No Abstract]   [Full Text] [Related]  

  • 18. Further discussion on the design and analysis of thorough QTc clinical trials: guest editors' notes.
    Tsong Y; Zhang J
    J Biopharm Stat; 2010 May; 20(3):493-6. PubMed ID: 20358431
    [No Abstract]   [Full Text] [Related]  

  • 19. The clinician as investigator: participating in clinical trials in the practice setting: Appendix 1: fundamentals of study design.
    Lader EW; Cannon CP; Ohman EM; Newby LK; Sulmasy DP; Barst RJ; Fair JM; Flather M; Freedman JE; Frye RL; Hand MM; Jesse RL; Van de Werf F; Costa F;
    Circulation; 2004 Jun; 109(21):e302-4. PubMed ID: 15173052
    [No Abstract]   [Full Text] [Related]  

  • 20. Analyzing and Interpreting Clinical Trials.
    Spino C
    Gastroenterology; 2016 Apr; 150(4):797-800. PubMed ID: 26924090
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.